person · Reporting owner
Grasman Jeroen Nicolaas
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Vaxart, Inc.VXRT · Entity 6654 | Chief Financial Officer | May 19, 2026 | May 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Vaxart, Inc.
Report date May 19, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 545,605 |
Reported balance
After 2026-05-19 transaction · row 1
1 source rowRow 1 · 2026-05-19 · Tax withholding · Disposed 31,395 · Balance 545,605 F1: Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of May 19, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of May 19, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 19, 2026 Filed May 21, 2026 21:13 UTC | Vaxart, Inc. VXRT · Entity 6654 | Tax withholdingCommon Stock | 31,395 | $0.61 | $19,150.95 |
DisclosureSEC source: 0001437749-26-018117 · rdgdoc.xml · nonDerivative · entry 1 Grasman Jeroen Nicolaas · CIK 0002067766 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 545,605 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of May 19, 2026. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 23:42 UTC | Vaxart, Inc. VXRT · Entity 6654 | GrantStock Option (right to buy) · Derivative | 455,000 | $0.00 Strike: $0.68 | $0.00 |
DisclosureSEC source: 0001437749-26-008908 · rdgdoc.xml · derivative · entry 2 Grasman Jeroen Nicolaas · CIK 0002067766 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 455,000 Underlying: Common Stock · 455,000 shares Expires 2036-03-16 F2 · derivative.exercise_date: The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 16, 2027, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 16, 2030. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 23:42 UTC | Vaxart, Inc. VXRT · Entity 6654 | GrantCommon Stock | 227,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-008908 · rdgdoc.xml · nonDerivative · entry 1 Grasman Jeroen Nicolaas · CIK 0002067766 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 577,000 F1 · shares: Grant of shares upon vesting of restricted stock units. 25% of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 16, 2026, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date. Read SEC document |
| May 19, 2025 Filed May 20, 2025 14:45 UTC | Vaxart, Inc. VXRT · Entity 6654 | GrantStock Option (right to buy) · Derivative | 1,000,000 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0001437749-25-017732 · rdgdoc.xml · derivative · entry 2 Grasman Jeroen Nicolaas · CIK 0002067766 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2035-05-19 F2 · derivative.exercise_date: The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on May 19, 2026, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on May 19, 2029. Read SEC document |
| May 19, 2025 Filed May 20, 2025 14:45 UTC | Vaxart, Inc. VXRT · Entity 6654 | GrantCommon Stock | 350,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-017732 · rdgdoc.xml · nonDerivative · entry 1 Grasman Jeroen Nicolaas · CIK 0002067766 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,000 F1 · shares: Grant of shares upon vesting of restricted stock units. Twenty five percent of the shares underlying the award shall vest on each anniversary of the vesting commencement date of May 19, 2025, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.